<--- Back to Details
First PageDocument Content
Licensee estoppel / Assignor estoppel / Estoppel / Patent / Lear /  Inc. v. Adkins / MedImmune /  Inc. v. Genentech /  Inc. / United States antitrust law / Contract / Law / United States patent law / Contract law
Date: 2009-12-27 21:07:06
Licensee estoppel
Assignor estoppel
Estoppel
Patent
Lear
Inc. v. Adkins
MedImmune
Inc. v. Genentech
Inc.
United States antitrust law
Contract
Law
United States patent law
Contract law

Microsoft Word - 19_14 hp紀要原稿「アン(英文)」080827岩井

Add to Reading List

Source URL: www.iip.or.jp

Download Document from Source Website

File Size: 159,15 KB

Share Document on Facebook

Similar Documents

AstraZeneca / Vaccines / Influenza vaccines / RTT / Flu pandemic / Live attenuated influenza vaccine / MedImmune / Ketamine

One MedImmune Way Gaithersburg, MDTO: Immunization Provider or Awardee

DocID: 1pDIX - View Document

MedImmune and Tanabe Research Laboratories / Mitsubishi Tanabe Pharma Enter into Strategic Collaboration and Licensing Agreement for the Development of Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugates to Treat

DocID: 1lU0o - View Document

Green Registry 2015 Leadership Award Winner AstraZeneca/MedImmune n About AstraZeneca/MedImmune

DocID: 1l9EK - View Document

July 22, 2014 Advaxis and MedImmune Partner on Immuno-Oncology Combination Clinical Trial PRINCETON, N.J., July 22, 2014 (GLOBE NEWSWIRE) --Advaxis, Inc.

DocID: 1jdz3 - View Document

Health / Medicine / Mononegavirales / Human respiratory syncytial virus / Biology / Bronchiolitis / MedImmune / Influenza vaccine / AstraZeneca / Viral diseases / Palivizumab

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SYNAGIS safely and effectively. See full prescribing information for SYNAGIS. SYNAGIS® (palivizumab) injection, for

DocID: 1gqM3 - View Document